T1	intervention 67 89	neoadjuvant lobaplatin
T2	total-participants 397 400	125
T3	control-participants 411 413	63
T4	intervention-participants 421 423	62
T5	outcome 590 630	rate of pCR in the breast and the axilla
T6	iv-bin-percent 534 539	38.7%
T7	cv-bin-percent 544 549	12.7%
T8	outcome 646 667	overall response rate
T9	iv-bin-percent 674 679	93.5%
T10	cv-bin-percent 684 689	73.0%
T11	outcome 721 737	grade 3-4 anemia
T12	outcome 742 758	thrombocytopenia
T13	iv-bin-percent 787 792	52.5%
T14	cv-bin-percent 797 802	10.0%
T15	iv-bin-percent 807 812	34.4%
T16	cv-bin-percent 817 821	1.7%
T17	control 414 416	TE
